Innate Pharma (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces its participation to the following analyst and investor conferences in the coming weeks:

• CF&B Smallcap Event, April 12-13, 2010, in Paris, France: Innate Pharma will meet with French investors specialized in small and midcap companies;
• BioEquity Europe, May 19-20, 2010, in Zurich, Switzerland: Hervé Brailly, CEO of Innate Pharma, will present the Company to European investors specialized in the biotech and healthcare sectors.